Drug Trial Radar · NCT04822883
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
Last checked: Nov 19, 2026Latest source record: Apr 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Apr 26, 2021
Primary completion
Oct 28, 2021
Study completion Oct 28, 2021
Sponsor
- Lead sponsor
- Recognify Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- Mar 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and effects on electrical activity in the brain of an investigational drug (RL-007) for improving cognition in patients with schizophrenia
Conditions
- Cognitive Impairment
- Schizophrenia
Interventions
RL-007Drug
Cohorts are 10 mg, 20 mg, 40 mg, and 80 mg with TID dosing
RL-007 Matching PlaceboDrug
Cohorts are 10 mg, 20 mg, 40 mg, and 80 mg with TID dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent Adverse Events (TEAE)Time frame: Study Day 8.
- Change in blood pressure (systolic and diastolic) from baselineTime frame: Study Day 4
- Change in heart rate from baselineTime frame: Study Day 4
- Change in respiratory rate from baselineTime frame: Study Day 4
- Change in temperature from baselineTime frame: Study Day 4
- Change in electrocardiogram (ECG) from baselineTime frame: Study Day 3
- Change in the Columbia Suicide Severity Rating Scale (C-SSRS) from baselineTime frame: Study Day 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Collaborative Neuroscience Research
Long Beach, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.